These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 14619187)

  • 1. [Hypercholesterolemia as cardiovascular risk in hypertensive patients. Therapeutic implications: efficiency of statins].
    Borghi C; Veronesi M
    Recenti Prog Med; 2003 Oct; 94(10):421-6. PubMed ID: 14619187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins in hypertension: are they a new class of antihypertensive agents?
    Feldstein CA
    Am J Ther; 2010; 17(3):255-62. PubMed ID: 19918164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardiovascular prevention: not necessary under the age of 40].
    Walma EP
    Ned Tijdschr Geneeskd; 2009; 153():B351. PubMed ID: 19785804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Type 2 diabetes and cardiovascular risk: lessons from therapeutic trials].
    Lièvre M
    Rev Prat; 2001 Oct; 51(16):1793-9. PubMed ID: 11795124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention of cardiovascular diseases in elderly subjects with hypercholesterolemia].
    Bruckert E; Giral P
    Therapie; 2000; 55(6):669-74. PubMed ID: 11234461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypercholesterolemia, cardiovascular risk, and hypocholesteremic treatment in the elderly].
    Cicconetti P; Ciotti V; Tafaro L; Riolo N; Marigliano V
    Recenti Prog Med; 2002 Apr; 93(4):264-72. PubMed ID: 11989134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The SaM (Screening and Monitoring) approach to cardiovascular risk-reduction in primary care--cyclic monitoring and individual treatment of patients at cardiovascular risk using the electronic medical record.
    Rabinowitz I; Tamir A
    Eur J Cardiovasc Prev Rehabil; 2005 Feb; 12(1):56-62. PubMed ID: 15703507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention of cardiovascular complications after a stroke or TIA: hypotensive and hypocholesterolemic therapy].
    Dippel DW; van der Worp HB
    Ned Tijdschr Geneeskd; 2004 Apr; 148(17):820-4. PubMed ID: 15141647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular protection paradigms: is change on the horizon?
    Papademetriou V
    Rev Cardiovasc Med; 2007; 8(4):200-13. PubMed ID: 18192943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypertension as a part of metabolic cardiovascular syndrome].
    Os I; Hjermann I; Nordby G
    Tidsskr Nor Laegeforen; 1991 Oct; 111(25):3062-4. PubMed ID: 1948918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The statin studies: from targeting hypercholesterolaemia to targeting the high-risk patient.
    Ong HT
    QJM; 2005 Aug; 98(8):599-614. PubMed ID: 16006501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of cholesterol abnormalities.
    Lockman AR; Tribastone AD; Knight KV; Franko JP
    Am Fam Physician; 2005 Mar; 71(6):1137-42. PubMed ID: 15791891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension and associated cardiovascular risk factors in Kelantan.
    Mafauzy M; Mokhtar N; Wan Mohamad WB
    Med J Malaysia; 2003 Oct; 58(4):556-64. PubMed ID: 15190632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lowering cholesterol: how low is low enough?].
    Czuriga I; Edes I
    Orv Hetil; 2006 Jul; 147(29):1349-56. PubMed ID: 16941825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypertension management in general practice in Iceland].
    Jensdóttir JO; Sigurethsson EL; Thornorgeirsson G
    Laeknabladid; 2006 May; 92(5):375-80. PubMed ID: 16741320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypercholesterolemia and hypertension--equivalent risk factors?].
    Kaufmann G
    Schweiz Rundsch Med Prax; 1991 Nov; 80(46):1272-7. PubMed ID: 1957090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics and molecular biology: rationale for targeting high-density lipoprotein cholesterol for therapeutic intervention.
    Mukherjee S
    Curr Opin Lipidol; 2006 Oct; 17(5):602-5. PubMed ID: 16960508
    [No Abstract]   [Full Text] [Related]  

  • 20. Ethical considerations in cardiovascular prevention.
    Follath F
    Fundam Clin Pharmacol; 2009 Dec; 23(6):669-73. PubMed ID: 19500153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.